Novel risk scoring system for metastatic renal cell carcinoma patients treated with cabozantinib.
Martini DJ, Kline MR, Liu Y, Shabto JM, Carthon BC, Russler GA, Yantorni L, Hitron EE, Caulfield S, Goldman JM, Harris WB, Kucuk O, Master VA, Bilen MA.
Martini DJ, et al. Among authors: master va.
Cancer Treat Res Commun. 2021;28:100393. doi: 10.1016/j.ctarc.2021.100393. Epub 2021 May 9.
Cancer Treat Res Commun. 2021.
PMID: 34029879
Free PMC article.